Please ensure Javascript is enabled for purposes of website accessibility
UCSF-Fresno Doctor Uses 'Promising' Drug on Covid-19 Patients
TLBBHMAP3-U010ALB5ANM-348f959abae2-512-300x300-1
By Jim Jakobs, Digital Producer
Published 5 years ago on
April 17, 2020

Share

It’s a four-syllable drug we may need to all learn by next month: “remdesivir.”
GV Wire spoke with the UCSF-Fresno doctor leading a local study on the drug. Dr. Eyad Almasri says he’s already given the drug to four patients, and the hospital has only had it in stock for a week.
“It is emerging as probably one of the most promising drugs (against) COVID-19,” Almasri said in an interview Thursday.

Originally Developed for SARS

According to UCSF-Fresno, remdesivir, a novel antiviral drug, was originally developed in 2002 for the first SARS and was tried on Ebola in 2014. Remdesivir has shown promising results treating COVID-19 in laboratory studies but hasn’t been validated on a wide scale for patients.

Scientific Approach

“Everyone is hoping that the drug will save many of our patients. But, but it’s still too soon to tell,” said Almasri. “We have to approach this in a scientific way, not our feelings.”
The Gilead Sciences drug has shown promise against other coronaviruses in the past. More than half of a group of severely ill coronavirus patients improved after receiving the antiviral drug, although there’s no way to know the odds of that happening without the drug because there was no comparison group, doctors reported on April 10.
Almasri acknowledged the need for science to take the lead: “Obviously we all have our own biases when we are dealing with our patients, so I want my patient to get better.”

1st Results in on Gilead Coronavirus Drug

The April 10 results were for 53 patients, ages 23 to 82, hospitalized in the United States, Europe, Canada, and Japan. Thirty-four of them were sick enough to require breathing machines.

All were given the drug through an IV for 10 days or as long as they tolerated it.

After 18 days on average, 36 patients, or 68%, needed less oxygen or breathing machine support. Eight others worsened.

Fresno Doctor Urges Caution

“I have anecdotal improvement, one of the first patients who was placed on the drug is getting better,” said Almasri. He continued, “But I have to warn you that (after) the standard of supportive care and a week of mechanical ventilation support, anyone else could have also gotten better, so I don’t want to attribute this to the drug.”
Almasri said he’s so far reserving the limited doses he has available for the patients exhibiting severe COVID-19 symptoms at Community Regional Medical Center and Clovis Community Hospital.
[covid-19-tracker]

Clinical Trials Nearing End

Data on trial testing of patients with moderate symptoms is expected in May.
CNBC reported that Gilead Sciences shares surged by more than 15% in after-hours trading Thursday after details leaked of a closely watched clinical trial of the company’s antiviral drug remdesivir, showing what appears to be promising results in treating Covid-19.
The University of Chicago’s phase 3 drug trial found that most of its patients had “rapid recoveries in fever and respiratory symptoms” and were discharged in less than a week, health-care publication STAT News reported.
Gilead’s clinical trial results involving patients with severe cases of the virus are expected this month.
UCSF-Fresno’s Dr. Almasri believes he sees a light at the end of the tunnel.
“I’m hoping that very soon, this drug will be approved, and it will be widely available.”
(The Associated Press contributed to this story.)

 
 
 

DON'T MISS

Elon Musk Reclaims Top Spot on Forbes’ Billionaires List

DON'T MISS

California Just Blew Its First Deadline for Voter-Approved Healthcare Measure

DON'T MISS

Trump Administration Halts Dozens of Research Grants at Princeton University

DON'T MISS

Fresno County Sheriff’s Pilot Takes His Last Flight as He Retires After 31 Years of Service

DON'T MISS

A Palestinian From the West Bank Is First Detainee Under 18 to Die in Israeli Prison, Officials Say

DON'T MISS

How Safe Is It to Walk to School? Fresno County Wants to Find Out

DON'T MISS

Baseball Is Back! How to Listen to Your MLB Favorites and the Grizzlies

DON'T MISS

Trump Says He’s Settled on a Tariff Plan That Is Set to Take Effect Wednesday

DON'T MISS

Auto Sales Surged in Anticipation of Trump’s Tariffs

DON'T MISS

Raid Or Rumor? Reports Of Immigrations Sweeps Are Warping Life In CA’s Central Valley

UP NEXT

California Just Blew Its First Deadline for Voter-Approved Healthcare Measure

UP NEXT

Fresno County Sheriff’s Pilot Takes His Last Flight as He Retires After 31 Years of Service

UP NEXT

Baseball Is Back! How to Listen to Your MLB Favorites and the Grizzlies

UP NEXT

Raid Or Rumor? Reports Of Immigrations Sweeps Are Warping Life In CA’s Central Valley

UP NEXT

Three Missing Fresno Teens Found Safe After Nine Days

UP NEXT

Lakers Hold Off Rockets With 6 3-Pointers Apiece From Dorian Finney-Smith, Gabe Vincent

UP NEXT

Athletics Bat Boy Stewart Thalblum Takes Down Drone in Left Field

UP NEXT

NFL Postpones Tush Push Decision but Passes Other Rule Changes, AP Source Says

UP NEXT

March Madness: It’s South Carolina vs. Texas and UCLA vs. UConn in Women’s Final Four

UP NEXT

Kings County Authorities Recover Stolen Tractor. Suspect Faces Prop 36 Penalty

Fresno County Sheriff’s Pilot Takes His Last Flight as He Retires After 31 Years of Service

3 hours ago

A Palestinian From the West Bank Is First Detainee Under 18 to Die in Israeli Prison, Officials Say

4 hours ago

How Safe Is It to Walk to School? Fresno County Wants to Find Out

4 hours ago

Baseball Is Back! How to Listen to Your MLB Favorites and the Grizzlies

5 hours ago

Trump Says He’s Settled on a Tariff Plan That Is Set to Take Effect Wednesday

5 hours ago

Auto Sales Surged in Anticipation of Trump’s Tariffs

5 hours ago

Raid Or Rumor? Reports Of Immigrations Sweeps Are Warping Life In CA’s Central Valley

6 hours ago

House Speaker Johnson Fails to Squash a Proxy Voting Effort From New Moms in Congress

6 hours ago

UN Agency Closes Its Remaining Gaza Bakeries as Food Supplies Dwindle Under Israeli Blockade

6 hours ago

Hooters Goes Bust and Files for Bankruptcy Protection

6 hours ago

Elon Musk Reclaims Top Spot on Forbes’ Billionaires List

Elon Musk has reclaimed his position as the world’s wealthiest individual, according to Forbes’ 39th annual World’s Billio...

37 minutes ago

37 minutes ago

Elon Musk Reclaims Top Spot on Forbes’ Billionaires List

3 hours ago

California Just Blew Its First Deadline for Voter-Approved Healthcare Measure

Nassau Hall at Princeton University is in Princeton, N.J., Oct. 8, 2024. (AP File)
3 hours ago

Trump Administration Halts Dozens of Research Grants at Princeton University

After 31 years of service, Fresno County Sheriff’s Deputy IV and Pilot Michael Sill is retiring, having logged over 10,000 flight hours.
3 hours ago

Fresno County Sheriff’s Pilot Takes His Last Flight as He Retires After 31 Years of Service

Khalid Ahmad holds a poster of his 17-year-old son, Waleed, who died in an Israeli prison, that reads in Arabic, "The hero prisoner Martyr, mercy and eternity for our righteous Martyrs," in the West Bank town of Silwad, northeast of Ramallah Wednesday, March 26, 2025. (AP/Nasser Nasser)
4 hours ago

A Palestinian From the West Bank Is First Detainee Under 18 to Die in Israeli Prison, Officials Say

4 hours ago

How Safe Is It to Walk to School? Fresno County Wants to Find Out

5 hours ago

Baseball Is Back! How to Listen to Your MLB Favorites and the Grizzlies

Vehicles at an Audi showroom in Miami, March 29, 2025. President Donald Trump has said that tariffs would encourage auto companies and their suppliers to move to the U.S. (Saul Martinez/The New York Times)
5 hours ago

Trump Says He’s Settled on a Tariff Plan That Is Set to Take Effect Wednesday

Help continue the work that gets you the news that matters most.

Search

Send this to a friend